Meropenem-Vaborbactam in the Treatment of Acute Bacterial Infections

This study reports the integrated analysis of two phase III studies of meropenem-vaborbactam in the treatment of acute bacterial infections. Targeting Antibiotic Non-Susceptible Gram-Negative Organisms (TANGO) I compared the clinical efficacy and tolerability of meropenem-vaborbactam and piperacilli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Chen, Chi-Chung, Tang, Hung-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832217/
https://www.ncbi.nlm.nih.gov/pubmed/31614430
http://dx.doi.org/10.3390/jcm8101650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832217/
https://www.ncbi.nlm.nih.gov/pubmed/31614430
http://dx.doi.org/10.3390/jcm8101650

Ejemplares similares